Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
Jean‐Michel Graciès(Université de Corse Pascal Paoli), Philippe Picaut(ThrustMe (France)), Béatrice Bois De Fer(Ipsen (France)), Claire Vilain(Ipsen (France)), Robert Jech(Charles University), Svetlana Khatkova(Ministry of Health of the Russian Federation), Fatma Gül(The University of Texas Southwestern Medical Center), F. Catus, Allison Brashear(Wake Forest University), Marta Banach(Jagiellonian University), Christina Marciniak(Northwestern University), А. А. Скоромец(First Pavlov State Medical University of St. Petersburg), Heather W. Walker(University of North Carolina at Chapel Hill), Thierry Deltombe(CHU Dinant Godinne UCL Namur), Peter Valkovič(Comenius University Bratislava), Peter McAllister, Steven R. Edgley(University of Utah)
Cited by 213
Related Papers
Pathophysiology of spastic paresis. II: Emergence of muscle overactivity
|Muscle & Nerve|2005|499
Short-term effects of dynamic Lycra splints on upper limb in hemiplegic patients
|Archives of Physical Medicine and Rehabilitation|2000|262
Traditional pharmacological treatments for spasticity part II: General and regional treatments
|Muscle & Nerve|1997|210
Botulinum Toxin Dilution and Endplate Targeting in Spasticity: A Double-Blind Controlled Study
|Archives of Physical Medicine and Rehabilitation|2009|185
Traditional pharmacological treatments for spasticity part I: Local treatments
|Muscle & Nerve|1997|146